List view / Grid view
2 June 2015 | By
Genticel has announced positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate...
6 February 2015 | By Genticel
Genticel announces that data obtained with ProCervix, its lead therapeutic vaccine, will be presented in the EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) 2015 Congress taking place at the FIBES II Conference and Exhibition Centre in Seville, Spain on February 4 – 7...
28 January 2015 | By Genticel
Genticel, a French biotechnology company and leading developer of therapeutic vaccines, announces its cash ans cash equivalents and liquid investments position and its highlights from the fourth quarter of 2014...
27 January 2015 | By Andrew Lloyd & Associates
The Data and Safety Monitoring Board (DSMB) identified no safety concerns that would require making changes to the conduct of the study...
